Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

Alliance HealthCare Services acquires 24/7 Radiology

Alliance HealthCare Services, Inc., a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced the acquisition of 24/7 Radiology, a professional radiology services company, which provides both preliminary and final professional radiology interpretation services for MRI, CT, ultrasound, X-Ray and other imaging modalities in 18 states.

15 Apr 2011

EPO grants patent to OncoGenex OGX-427 for prostate cancer treatment

OncoGenex Pharmaceuticals, Inc., today announced that the European Patent Office has granted European Patent Number EP1545561 entitled "Oligonucleotides for Treatment of Prostate and other Cancers."

15 Apr 2011

Study finds SAVI applicator for breast brachytherapy safe for women with breast implants

The SAVI® applicator for breast brachytherapy was used to safely deliver post-lumpectomy radiation therapy to a woman with breast implants, according to a newly published paper in a peer-reviewed journal. The case study showed that SAVI produced an "optimal" clinical outcome and "excellent cosmetic results that pleased the patient," wrote the authors.

12 Apr 2011

Hypericin may treat recurrent malignant brain tumors

Researchers have found that a synthetic version of hypericin, a compound naturally found in St. John's wort, may be a promising treatment for patients with recurrent malignant brain tumors. Their findings were published online on March 31, 2011 in the journal Cancer.

12 Apr 2011

Study finds pelvic anatomy differences following RARP and open prostatectomy

Researchers from Boston University School of Medicine have concluded that the anatomy of the pelvis following robotic-assisted radical prostatectomy.

12 Apr 2011

Elekta to highlight Leksell Gamma Knife Perfexion radiosurgery solution at AANS 2011

At the 2011 American Association of Neurological Surgeons (AANS) Annual Meeting, April 9-13 at the Colorado Convention Center, Elekta (booth #1717) will highlight characteristics of Leksell Gamma Knife® Perfexion™ that separate the system from other radiosurgery solutions.

From Elekta 8 Apr 2011

BSD Medical second quarter net loss decreases 19% to $1,554,000

BSD Medical Corporation, a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today reported financial results for its second fiscal quarter ended February 28, 2011.

8 Apr 2011

Persistent fatigue in breast cancer survivors may be caused by autonomic nervous system running in overdrive

The persistent fatigue that plagues one out of every three breast cancer survivors may be caused by one part of the autonomic nervous system running in overdrive, while the other part fails to slow it down.

7 Apr 2011

Living human taste cells maintained in culture for seven months

Following years of futile attempts, new research from the Monell Center demonstrates that living human taste cells can be maintained in culture for at least seven months. The findings provide scientists with a valuable tool to learn about the human sense of taste and how it functions in health and disease.

7 Apr 2011

OncoGenex presents OGX-427 preclinical data in prostrate cancer at AACR meeting

OncoGenex Pharmaceuticals, Inc. announced today that preclinical data utilizing their pipeline compound OGX-427 was presented at the AACR 102nd Annual Meeting 2011.

5 Apr 2011

Synta presents ganetespib and elesclomol study data in cancer at AACR meeting

Synta Pharmaceuticals Corp. today presented five posters at the American Association for Cancer Research 102nd Annual Meeting. Three posters reported results from studies of ganetespib, and two posters reported results from studies of elesclomol, a small-molecule mitochondria metabolism inhibitor.

5 Apr 2011

Oncology experts educate lawmakers about latest information on radiation therapy

Leaders from the radiation oncology community – representing patients, physicians, providers, and manufacturers – met on Capitol Hill today to educate lawmakers and their staffs about the latest in radiation therapy technologies and techniques, improvements in patient care and the community's focus on patient safety in radiation therapy delivery.

1 Apr 2011

TNM 7 system can predict lung cancer recurrence after surgery

The new TNM 7 lung cancer staging system seems to be a better predictor of local or regional recurrence of lung cancer following surgery, according to a study published in the April issue of the Journal of Thoracic Oncology.

1 Apr 2011

Study finds Gamma Knife procedure effective for brain metastases treatment

The volume of normal brain tissue exposed to radiation during treatment for multiple metastases appears to depend on which stereotactic radiosurgery system is employed, according to a recent study in the Journal of Neurosurgery.

31 Mar 2011

Radiation oncologists head to Capitol Hill to promote critical initiatives

More than 100 radiation oncology treatment team members and resident physicians convened in Washington Monday and Tuesday to represent radiation oncology on Capitol Hill at the American Society for Radiation Oncology's (ASTRO) eighth annual Advocacy Day. Participants spent Monday hearing from members of Congress and key congressional staff on the latest legislative activity and ASTRO'’s legislative agenda. On Tuesday, the group headed to House and Senate office buildings to meet with senators, congressmen and staffers from their home states to promote agenda items important to the safety and well-being of cancer patients.

30 Mar 2011

Carl Zeiss Meditec’s MEL 80 Excimer Laser receives PMA from FDA to treat hyperopia

Carl Zeiss Meditec, Inc. announced today that the MEL 80 Excimer Laser has received premarket approval from the U.S. Food and Drug Administration for the treatment of hyperopia.

29 Mar 2011

Science Magazine reports on recent push to make preventing, treating cancer a global priority

Science Magazine reports on the recent push to make preventing and treating cancer a global priority, particularly in developing countries, where it's estimated "less than 5% of the world's cancer resources are spent."

28 Mar 2011

Scientists identify protein that plays a key role in cancer treatment resistance

Research led by Daitoku Sakamuro, PhD, Assistant Professor of Pathology at LSU Health Sciences Center New Orleans and the LSUHSC Stanley S. Scott Cancer Center, has identified a protein that enables the activation of a DNA-repair enzyme that protects cancer cells from catastrophic damage caused by chemo and radiation therapy.

25 Mar 2011

Jefferson Hospitals uses VMAT and Monte Carlo technology for accurate and fast radiation therapy

The Radiation Oncology Department at Thomas Jefferson University Hospitals is now treating cancer patients using a state-of-the-art VMAT technology based on the most accurate dose calculation algorithm that dramatically shortens treatment delivery time.

25 Mar 2011

Resveratrol can provide resistance before and after hazardous radiation exposure

Clinical studies of Resveratrol--recognized for its proven role in activating the longevity gene to inhibit age-related diseases--have shown that its antioxidant power provides resistance before and after exposure to hazardous radiation.

24 Mar 2011

Radiation Therapy News and Research

Further Reading

Alliance HealthCare Services acquires 24/7 Radiology

EPO grants patent to OncoGenex OGX-427 for prostate cancer treatment

Study finds SAVI applicator for breast brachytherapy safe for women with breast implants

Hypericin may treat recurrent malignant brain tumors

Study finds pelvic anatomy differences following RARP and open prostatectomy

Elekta to highlight Leksell Gamma Knife Perfexion radiosurgery solution at AANS 2011

BSD Medical second quarter net loss decreases 19% to $1,554,000

Persistent fatigue in breast cancer survivors may be caused by autonomic nervous system running in overdrive

Living human taste cells maintained in culture for seven months

OncoGenex presents OGX-427 preclinical data in prostrate cancer at AACR meeting

Synta presents ganetespib and elesclomol study data in cancer at AACR meeting

Oncology experts educate lawmakers about latest information on radiation therapy

TNM 7 system can predict lung cancer recurrence after surgery

Study finds Gamma Knife procedure effective for brain metastases treatment

Radiation oncologists head to Capitol Hill to promote critical initiatives

Carl Zeiss Meditec’s MEL 80 Excimer Laser receives PMA from FDA to treat hyperopia

Science Magazine reports on recent push to make preventing, treating cancer a global priority

Scientists identify protein that plays a key role in cancer treatment resistance

Jefferson Hospitals uses VMAT and Monte Carlo technology for accurate and fast radiation therapy

Resveratrol can provide resistance before and after hazardous radiation exposure

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News